PD04 Economic Evaluation Of Neonatal Screening Strategies For Congenital Cytomegalovirus In Spain
Guillem Torres-Pagès, Jessica Ruiz-Baena, M. Pellicer, Ana Alarcón, Maria Dolors Estrada Sabadell, Rosa Maria Vivanco-Hidalgo · 2025
Read PD04 Economic Evaluation Of Neonatal Screening Strategies For Congenital Cytomegalovirus In Spain by Guillem Torres-Pagès, Jessica Ruiz-Baena, M. Pellicer, Ana Alarcón, Maria Dolors Estrada Sabadell, Rosa Maria Vivanco-Hidalgo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768785.txt.
Description
Guillem Torres-Pagès and co-authors wrote a 2025 study on the cost of screening newborns in Spain for a virus called congenital cytomegalovirus. Babies born with the virus can lose hearing or face delays in brain growth. Finding the virus at birth lets doctors act early, but screening every baby costs money.
The team compared three plans: testing all babies with a saliva test, testing only babies who fail a hearing check, and waiting for signs of illness. Testing all babies found 1,547 cases at birth, far more than the other plans. It also left fewer children with hearing loss years later. The cost per year of healthy life gained was about 33,225 euros. The study gives health leaders in Spain a clear base for a screening choice.
Catalog record
| CREATOR | Guillem Torres-Pagès, Jessica Ruiz-Baena, M. Pellicer, Ana Alarcón, Maria Dolors Estrada Sabadell, Rosa Maria Vivanco-Hidalgo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |